Proteomics-Int retweeted
In a world-first, #biotech company @proteomics_int has discovered a predictive diagnostic test to help manage one of the complications of #diabetes and a leading cause of death — diabetic kidney disease (DKD). Read more: bit.ly/2XxEdSy
Announced at #2018DTM proteomics.com.au/promarkerd…
We look forward to seeing you at the Diabetes Technology Meeting in Bethesda next week! Use #2018DTM to tweet about the meeting! diabetestechnology.org/dtm/
Proteomics-Int retweeted
.@proteomics_int Receives $834k Federal R&D Tax Incentive - subscribe to Biotech Daily biotechdaily.com.au
Proteomics-Int retweeted
.@proteomics_int Licences Promarkerd For Spain; Wins WA Gong - subscribe to Biotech Daily biotechdaily.com.au
Aussie test helps 30 million USA diabetic patients #AFR #AustralianFinancialReview #PromarkerD #diabetes
Proteomics-Int retweeted
.@proteomics_int Revenue Up 27% To $1.2m, Loss Up 57% To $1.4m - subscribe to Biotech Daily biotechdaily.com.au
Proteomics-Int retweeted
.@proteomics_int $3.4m March 31 Options Underwritten - subscribe to Biotech Daily biotechdaily.com.au
Proteomics International Investing in CPR Pharma Services | 360Dx ow.ly/59ga30inAF4
BRIEF-Proteomics International Laboratories Updates On Investment In CPR Pharma Services | Reuters ow.ly/FGqc30inAvC
Proteomics International Announces Strategic Alliance and Investment in CPR Pharma Services | BioSpace ow.ly/dc3k30inApS
Proteomics International announces Strategic Alliance and Investment in CPR Pharma Services prwire.com.au/pr/75319/prote…
Pharma Letter BRIEF—Proteonomics buys stake in CPR Pharma ow.ly/1kRK30inA8S
Proteomics International Investing in CPR Pharma Services | GenomeWeb ow.ly/bFmL30inA6J
New biomarkers may accurately identify renal disease in type 2 diabetes patients - ow.ly/ZVYp30fSpAx ow.ly/P8va30fSpAy #DKD
#promarkerD best in world featured in DDN ddn-news.com/index.php?newsa…






